Epalrestat effect on diabetic neuropathy in primary care setting

Epalrestat effect on diabetic neuropathy in primary care setting - Epalrestat effect on diabetic neuropathy in primary care setting

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001662

Enrollment

200

Registered

2009-01-28

Start date

2009-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic neuropathy

Interventions

treatment by epalrestat observation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient with diabetic neuropathy and written informed consent obtained

Exclusion criteria

Exclusion criteria: not specified

Design outcomes

Primary

Measure	Time frame
symptom score of patient questionnaire	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026